Clinical Trial Update: Phase 1 Study for Safety and Tolerability of EBI-005 Topically Administered to Eyes of Healthy Adult Subjects [Phase 1]

View source ↗

Summary

This Phase 1 trial reports the safety and tolerability of topically applied EBI-005 in healthy adult volunteers in the context of dry eye disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• EBI-005

Snippet

Sponsor: Eleven Biotherapeutics | Conditions: Dry Eye | Phase 1 | Status: COMPLETED